/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mark D. Rothmann

United States Food and Drug Administration(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

64

Papers

2.7K

Citations

19

h-index

25

i10-index

Mark D. Rothmann is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Statistical Methods in Clinical Trials & Health Systems, Economic Evaluations, Quality of Life & Advanced Causal Inference Techniques. The author has an h-index of 19, co-authored 55 publications.

ORCID: 0000-0002-1830-7057

Research Topics

Statistical Methods in Clinical Trials Health Systems, Economic Evaluations, Quality of Life Advanced Causal Inference Techniques Stochastic processes and statistical mechanics Statistical Methods and Bayesian Inference

Papers by this author

works

Design and analysis of non‐inferiority mortality trials in oncology

2002 · Statistics in Medicine · 241 citations

https://doi.org/10.1002/sim.1400

Mark D. Rothmann Ning Li Gang Chen Y. H. George

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

2022 · Therapeutic Innovation & Regulatory Science · 14 citations

https://doi.org/10.1007/s43441-022-00445-6

Thomas R. Fleming Christine Garnett Laurie S. Conklin Solange Corriol‐Rohou

Research topics

topics

Statistical Methods in Clinical Trials

Health Systems, Economic Evaluations, Quality of Life

Advanced Causal Inference Techniques

Stochastic processes and statistical mechanics

Statistical Methods and Bayesian Inference

Chat about Author

Papers

Chat

Click to start Chat